LaForce FM: Anthrax. Clin Infect Dis. 1994, 19: 1009-1013.
Article
CAS
PubMed
Google Scholar
Kasuya K, Boyer JL, Tan Y, Alipui DO, Hackett NR, Crystal RG: Passive immunotherapy for anthrax toxin mediated by an adenovirus expressing an anti-protective antigen single-chain antibody. Mol Ther. 2005, 11: 237-244. 10.1016/j.ymthe.2004.10.018.
Article
CAS
PubMed
Google Scholar
Beedham RJ, Turnbull PC, Williamson ED: Passive transfer of protection against Bacillus anthracis infection in a murine model. Vaccine. 2001, 19: 4409-4416. 10.1016/S0264-410X(01)00197-9.
Article
CAS
PubMed
Google Scholar
Kobiler D, Gozes Y, Rosenberg H, Marcus D, Reuveny S, Altboum Z: Efficiency of protection of guinea pigs against infection with Bacillus anthracis spores by passive immunization. Infect Immun. 2002, 70: 544-560. 10.1128/IAI.70.2.544-550.2002.
Article
PubMed Central
CAS
PubMed
Google Scholar
Little SF, Ivins BE, Fellows PF, Friedlander AM: Passive protection by polyclonal antibodies against Bacillus anthracis infection in guinea pigs. Infect Immun. 1997, 65: 5171-5175.
PubMed Central
CAS
PubMed
Google Scholar
Casadevall A, Dadachova E, Pirofski LA: Passive antibody therapy for infectious diseases. Nat Rev Microbiol. 2004, 2: 695-703. 10.1038/nrmicro974.
Article
CAS
PubMed
Google Scholar
Casadevall A: Passive antibody administration (immediate immunity) as a specific defense against biological weapons. Emerg Infect Dis. 2002, 8: 833-841.
Article
PubMed Central
CAS
PubMed
Google Scholar
Casadevall A, Pirofski LA: The potential of antibody-mediated immunity in the defence against biological weapons. Expert Opin Biol Ther. 2005, 5: 1359-1372. 10.1517/14712598.5.10.1359.
Article
CAS
PubMed
Google Scholar
Casadevall A, Scharff MD: Serum therapy revisited: animal models of infection and development of passive antibody therapy. Antimicrob Agents Chemother. 1994, 38: 1695-1702.
Article
PubMed Central
CAS
PubMed
Google Scholar
Casadevall A, Scharff MD: Return to the past: the case for antibody-based therapies in infectious diseases. Clin Infect Dis. 1995, 21: 150-161.
Article
CAS
PubMed
Google Scholar
Jahrling PB, Geisbert J, Swearengen JR, Jaax GP, Lewis T, Huggins JW, Schmidt JJ, LeDuc JW, Peters CJ: Passive immunization of Ebola virus-infected cynomolgus monkeys with immunoglobulin from hyperimmune horses. Arch Virol Suppl. 1996, 11: 135-140.
CAS
PubMed
Google Scholar
Jahrling PB, Geisbert TW, Geisbert JB, Swearengen JR, Bray M, Jaax NK, Huggins JW, LeDuc JW, Peters CJ: Evaluation of immune globulin and recombinant interferon-alpha2b for treatment of experimental Ebola virus infections. J Infect Dis. 1999, 179 Suppl 1: S224-S234.
Article
CAS
PubMed
Google Scholar
Collier RJ, Young JA: Anthrax toxin. Annu Rev Cell Dev Biol. 2003, 19: 45-70. 10.1146/annurev.cellbio.19.111301.140655.
Article
CAS
PubMed
Google Scholar
Lacy DB, Collier RJ: Structure and function of anthrax toxin. Curr Top Microbiol Immunol. 2002, 271: 61-85.
CAS
PubMed
Google Scholar
Moayeri M, Leppla SH: The roles of anthrax toxin in pathogenesis. Curr Opin Microbiol. 2004, 7: 19-24. 10.1016/j.mib.2003.12.001.
Article
CAS
PubMed
Google Scholar
Leppla SH: Anthrax toxin edema factor: a bacterial adenylate cyclase that increases cyclic AMP concentrations of eukaryotic cells. Proc Natl Acad Sci U S A. 1982, 79: 3162-3166. 10.1073/pnas.79.10.3162.
Article
PubMed Central
CAS
PubMed
Google Scholar
Duesbery NS, Webb CP, Leppla SH, Gordon VM, Klimpel KR, Copeland TD, Ahn NG, Oskarsson MK, Fukasawa K, Paull KD, Vande Woude GF: Proteolytic inactivation of MAP-kinase-kinase by anthrax lethal factor. Science. 1998, 280: 734-737. 10.1126/science.280.5364.734.
Article
CAS
PubMed
Google Scholar
Barth H, Aktories K, Popoff MR, Stiles BG: Binary bacterial toxins: biochemistry, biology, and applications of common Clostridium and Bacillus proteins. Microbiol Mol Biol Rev. 2004, 68: 373-402, table. 10.1128/MMBR.68.3.373-402.2004.
Article
PubMed Central
CAS
PubMed
Google Scholar
Dezube BJ, Proper J, Zhang J, Choy VJ, Weeden W, Morrissey J, Burns EM, Dixon JD, O'Loughlin C, Williams LA, Pickering PJ, Crumpacker CS, Gelder FB: A passive immunotherapy, (PE)HRG214, in patients infected with human immunodeficiency virus: a phase I study. J Infect Dis. 2003, 187: 500-503. 10.1086/367710.
Article
CAS
PubMed
Google Scholar
Pett SL, Williams LA, Day RO, Lloyd AR, Carr AD, Clezy KR, Emery S, Kaplan E, McPhee DA, McLachlan AJ, Gelder FB, Lewin SR, Liauw W, Williams KM: A phase I study of the pharmacokinetics and safety of passive immunotherapy with caprine anti-HIV antibodies, (PE)HRG214, in HIV-1-infected individuals. HIV Clin Trials. 2004, 5: 91-98. 10.1310/1FLN-8KFC-5HEQ-K19J.
Article
PubMed
Google Scholar
Verity EE, Williams LA, Haddad DN, Choy V, O'Loughlin C, Chatfield C, Saksena NK, Cunningham A, Gelder F, McPhee DA: Broad neutralization and complement-mediated lysis of HIV-1 by PEHRG214, a novel caprine anti-HIV-1 polyclonal antibody. AIDS. 2006, 20: 505-515. 10.1097/01.aids.0000210604.78385.95.
Article
CAS
PubMed
Google Scholar
Ahuja N, Kumar P, Bhatnagar R: Rapid purification of recombinant anthrax-protective antigen under nondenaturing conditions. Biochem Biophys Res Commun. 2001, 286: 6-11. 10.1006/bbrc.2001.5337.
Article
CAS
PubMed
Google Scholar
Chauhan V, Singh A, Waheed SM, Singh S, Bhatnagar R: Constitutive expression of protective antigen gene of Bacillus anthracis in Escherichia coli. Biochem Biophys Res Commun. 2001, 283: 308-315. 10.1006/bbrc.2001.4777.
Article
CAS
PubMed
Google Scholar
Sawada-Hirai R, Jiang I, Wang F, Sun SM, Nedellec R, Ruther P, Alvarez A, Millis D, Morrow PR, Kang AS: Human anti-anthrax protective antigen neutralizing monoclonal antibodies derived from donors vaccinated with anthrax vaccine adsorbed. J Immune Based Ther Vaccines. 2004, 2: 5-10.1186/1476-8518-2-5.
Article
PubMed Central
PubMed
Google Scholar
Vitale L, Blanset D, Lowy I, O'Neill T, Goldstein J, Little SF, Andrews GP, Dorough G, Taylor RK, Keler T: Prophylaxis and therapy of inhalational anthrax by a novel monoclonal antibody to protective antigen that mimics vaccine-induced immunity. Infect Immun. 2006, 74: 5840-5847. 10.1128/IAI.00712-06.
Article
PubMed Central
CAS
PubMed
Google Scholar
Herrmann JE, Wang S, Zhang C, Panchal RG, Bavari S, Lyons CR, Lovchik JA, Golding B, Shiloach J, Lu S: Passive immunotherapy of Bacillus anthracis pulmonary infection in mice with antisera produced by DNA immunization. Vaccine. 2006, 24: 5872-5880. 10.1016/j.vaccine.2006.04.065.
Article
CAS
PubMed
Google Scholar
Reuveny S, White MD, Adar YY, Kafri Y, Altboum Z, Gozes Y, Kobiler D, Shafferman A, Velan B: Search for correlates of protective immunity conferred by anthrax vaccine. Infect Immun. 2001, 69: 2888-2893. 10.1128/IAI.69.5.2888-2893.2001.
Article
PubMed Central
CAS
PubMed
Google Scholar
Bush SP, Green SM, Moynihan JA, Hayes WK, Cardwell MD: Crotalidae polyvalent immune Fab (ovine) antivenom is efficacious for envenomations by Southern Pacific rattlesnakes (Crotalus helleri). Ann Emerg Med. 2002, 40: 619-624. 10.1067/mem.2002.129939.
Article
PubMed
Google Scholar
Jones RG, Lee L, Landon J: The effects of specific antibody fragments on the 'irreversible' neurotoxicity induced by Brown snake (Pseudonaja) venom. Br J Pharmacol. 1999, 126: 581-584. 10.1038/sj.bjp.0702286.
Article
PubMed Central
CAS
PubMed
Google Scholar
Jones RG, Corteling RL, Bhogal G, Landon J: A novel Fab-based antivenom for the treatment of mass bee attacks. Am J Trop Med Hyg. 1999, 61: 361-366.
CAS
PubMed
Google Scholar
Tripp RA, Moore D, Winter J, Anderson LJ: Respiratory syncytial virus infection and G and/or SH protein expression contribute to substance P, which mediates inflammation and enhanced pulmonary disease in BALB/c mice. J Virol. 2000, 74: 1614-1622. 10.1128/JVI.74.4.1614-1622.2000.
Article
PubMed Central
CAS
PubMed
Google Scholar
Rivera J, Nakouzi A, Abboud N, Revskaya E, Goldman D, Collier RJ, Dadachova E, Casadevall A: A monoclonal antibody to Bacillus anthracis protective antigen defines a neutralizing epitope in domain 1. Infect Immun. 2006, 74: 4149-4156. 10.1128/IAI.00150-06.
Article
PubMed Central
CAS
PubMed
Google Scholar
Brossier F, Levy M, Landier A, Lafaye P, Mock M: Functional analysis of Bacillus anthracis protective antigen by using neutralizing monoclonal antibodies. Infect Immun. 2004, 72: 6313-6317. 10.1128/IAI.72.11.6313-6317.2004.
Article
PubMed Central
CAS
PubMed
Google Scholar
Mabry R, Rani M, Geiger R, Hubbard GB, Carrion R, Brasky K, Patterson JL, Georgiou G, Iverson BL: Passive protection against anthrax by using a high-affinity antitoxin antibody fragment lacking an Fc region. Infect Immun. 2005, 73: 8362-8368. 10.1128/IAI.73.12.8362-8368.2005.
Article
PubMed Central
CAS
PubMed
Google Scholar